
Biological Activity
PDGFRβ and B-Raf allosteric inhibitor. Also inhibits c-Raf, FLT3 and KIT. Disrupts blood vessel formation in zebrafish embryos and inhibits angiogenesis in a mouse angiogenesis model. Inhibits growth of renal and pancreatic tumors in mice. Also arrests cells in prometaphase. Orally available.
Compound Libraries
KG 5 is also offered as part of the Tocriscreen Plus. Find out more about compound libraries available from Tocris.
Technical Data
M. Wt | 459.45 |
Formula | C20H16F3N7OS |
Storage | Store at -20°C |
Purity | ≥98% (HPLC) |
CAS Number | 877874-85-6 |
PubChem ID | 53328059 |
InChI Key | CMYHZFCJPORPHY-UHFFFAOYSA-N |
Smiles | NC1=NC(SC)=NC(OC(C=C4)=CC=C4C3=NN=C(N3)NC2=CC(C(F)(F)F)=CC=C2)=C1 |
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Solubility Data
Solvent | Max Conc. mg/mL | Max Conc. mM | |
---|---|---|---|
Solubility | |||
DMSO | 45.94 | 100 | |
ethanol | 45.94 | 100 |
Preparing Stock Solutions
The following data is based on the product molecular weight 459.45. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
1 mM | 2.18 mL | 10.88 mL | 21.77 mL |
5 mM | 0.44 mL | 2.18 mL | 4.35 mL |
10 mM | 0.22 mL | 1.09 mL | 2.18 mL |
50 mM | 0.04 mL | 0.22 mL | 0.44 mL |
Molarity Calculator
Reconstitution Calculator
Dilution Calculator
Product Datasheets
References
References are publications that support the products' biological activity.
Murphy et al (2010) Disruption of angiogenesis and tumor growth with an orally active drug that stabilizes the inactive state of PDGFRbeta/B-RAF. Proc.Natl.Acad.Sci.U.S.A. 107 4299 PMID: 20154271
Mielgo et al (2011) A MEK-independent role for CRAF in mitosis and tumor progression. Nat.Med. 17 PMID: 22081024
Keywords: KG 5, supplier, KG5, KIT, FLT3, B-Raf, C-Raf, PDGFRbeta, PDGFRB, β, inhibitors, inhibits, anticancers, angiogenesis, antiangiogenics, FLT3, PDGFR, Other, RTKs, Raf, Kinase, Antiangiogenics, Raf, Kinase, Tocris Bioscience